GlassScriptPhysician profile
Daoud Dajani
NPI 1376786186
$46,735.00
in general payments reported to CMS, 2019-2025
42 companies · $15K in 2025
The $15K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $449 · 2023: $6,671 · 2024: $25K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $8,673 · Food and Beverage: $6,452 · Travel and Lodging: $3,717 · Honoraria: $250 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,170.54 |
| Consulting Fee | $8,673.42 |
| Food and Beverage | $6,451.51 |
| Travel and Lodging | $3,717.45 |
| Honoraria | $250.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $32,162.08 | 2023-2025 | Erleada, Akeega, Rybrevant |
| Ethicon INC. | $7,751.93 | 2025 | |
| Intuitive Surgical, INC. | $2,059.66 | 2022-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Teleflex LLC | $699.34 | 2022-2025 | Urolift |
| Sumitomo Pharma America, INC. | $335.64 | 2023-2025 | Orgovyx, Gemtesa |
| Progenics Pharmaceuticals, INC. | $334.50 | 2023-2025 | Pylarify |
| Myriad Genetic Laboratories, INC. | $314.95 | 2023-2024 | Prolaris |
| Dendreon Pharmaceuticals LLC | $289.63 | 2023-2025 | Provenge |
| Cook Incorporated | $250.00 | 2023 | |
| Medtronic, INC. | $236.49 | 2023 | Interstim |
| Immunitybio, INC. | $221.82 | 2024-2025 | |
| Urogen Pharma, INC. | $202.28 | 2023-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $186.27 | 2024-2025 | |
| Pfizer INC. | $178.39 | 2023-2025 | |
| Boston Scientific Corporation | $160.48 | 2022-2024 | Ams 700, Rezum Generator, Spaceoar Vue System - 10ml |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $159.83 | 2023-2025 | Botox |
| Conmed Corporation | $134.96 | 2022-2023 | Vcare, Conmed Specimen Retrieval, Airseal |
| Coloplast Corp | $98.46 | 2024-2025 | |
| Caldera Medical, INC | $78.87 | 2025 | |
| Merck Sharp & Dohme LLC | $74.05 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Astellas Pharma US INC | $69.04 | 2024-2025 | Xtandi, Myrbetriq, Veozah |
| Olympus America INC. | $67.78 | 2023-2024 | Itind System, Uretero-Reno Videoscope, Cysto-Nephro Videoscope |
| Tempus Ai, INC | $64.62 | 2024-2025 | Xt Cdx |
| Janssen Pharmaceuticals, INC | $55.56 | 2025 | Erleada |
| Endo USA, INC. | $42.47 | 2024 | Aveed, Xiaflex, Edex |
| Ferring Pharmaceuticals INC. | $42.28 | 2024-2025 | Adstiladrin |
| Telix Pharmaceuticals | $42.23 | 2024 | Illuccix |
| Axonics, INC. | $41.69 | 2023-2024 | Axonics |
| Endo Pharmaceuticals INC. | $39.38 | 2023 | Aveed, Xiaflex, Edex |
| Cook Medical LLC | $38.37 | 2024-2025 | Litho 150, Cook |
| Antares Pharma, INC. | $34.13 | 2024 | Xyosted |
| Abc Home Medical Supply, INC. | $32.33 | 2025 | |
| Novartis Pharmaceuticals Corporation | $31.36 | 2025 | |
| Blue Earth Diagnostics | $27.43 | 2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $25.92 | 2025 | Lynparza |
| Bioprotect Medical, INC. | $25.66 | 2025 | Bioprotect Balloon Implant System |
| Lantheus Medical Imaging, INC. | $25.24 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.88 | 2023 | Ofev |
| Photocure INC | $20.59 | 2024 | Cysview |
| Caris Mpi, INC. | $19.86 | 2025 | Mi Cancer Seek |
| Accord Healthcare, INC. | $19.56 | 2024 | |
| Ethicon US, LLC | $16.99 | 2023 | Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daoud Dajani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.